Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05953038
EARLY_PHASE1

LSD Occupancy of the Serotonin 2A Receptor in the Human Brain

Sponsor: Rigshospitalet, Denmark

View on ClinicalTrials.gov

Summary

The investigators wish to quantify the relation between administered dose of lysergic acid diethylamide (LSD), plasma LSD levels, and occupancy at the serotonin 2A receptor (5-HT2AR) using \[11C\]CIMBI-36 positron emission tomography.

Official title: Lysergic Acid Diethylamide Occupancy of the Serotonin 2A Receptor in the Human Brain

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2023-11-08

Completion Date

2027-12-31

Last Updated

2024-12-18

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Lysergic Acid Diethylamide Tartrate

D-Lysergic Acid Diethylamide (LSD) D-tartrate as oral drinking solution (water / ethanol 20% m/m)

Locations (1)

Neurobiology Research Unit, Rigshospitalet

Copenhagen, Denmark